REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 115 filers reported holding REVANCE THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.94 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $35,822,174 | -47.8% | 13,938,589 | -0.0% | 0.01% | -45.5% |
| Q1 2024 | $68,612,032 | -34.6% | 13,945,535 | +16.8% | 0.01% | -42.1% |
| Q4 2023 | $104,944,478 | -23.5% | 11,939,076 | -0.2% | 0.02% | -29.6% |
| Q3 2023 | $137,190,605 | -43.4% | 11,960,820 | +24.9% | 0.03% | -42.6% |
| Q2 2023 | $242,340,061 | -25.3% | 9,574,874 | -5.0% | 0.05% | -29.9% |
| Q1 2023 | $324,551,213 | +85.5% | 10,076,101 | +6.3% | 0.07% | +81.1% |
| Q4 2022 | $175,003,680 | -19.5% | 9,480,156 | +17.8% | 0.04% | -24.5% |
| Q3 2022 | $217,319,000 | +242.6% | 8,048,838 | +75.4% | 0.05% | +276.9% |
| Q2 2022 | $63,434,000 | -2.9% | 4,590,000 | +37.0% | 0.01% | +18.2% |
| Q1 2022 | $65,325,000 | +7.8% | 3,350,000 | -9.8% | 0.01% | +10.0% |
| Q4 2021 | $60,580,000 | -26.7% | 3,712,000 | +25.1% | 0.01% | -28.6% |
| Q3 2021 | $82,661,000 | -6.0% | 2,967,000 | 0.0% | 0.01% | -6.7% |
| Q2 2021 | $87,942,000 | +22.4% | 2,967,000 | +15.4% | 0.02% | +15.4% |
| Q1 2021 | $71,862,000 | +19.0% | 2,571,102 | +20.7% | 0.01% | +8.3% |
| Q4 2020 | $60,364,000 | +12.7% | 2,130,000 | 0.0% | 0.01% | 0.0% |
| Q3 2020 | $53,548,000 | +2.9% | 2,130,000 | 0.0% | 0.01% | -7.7% |
| Q2 2020 | $52,015,000 | +65.0% | 2,130,000 | 0.0% | 0.01% | +44.4% |
| Q1 2020 | $31,524,000 | -8.8% | 2,130,000 | 0.0% | 0.01% | +12.5% |
| Q4 2019 | $34,570,000 | +57.8% | 2,130,000 | +26.4% | 0.01% | +60.0% |
| Q3 2019 | $21,905,000 | +0.2% | 1,685,000 | 0.0% | 0.01% | 0.0% |
| Q2 2019 | $21,854,000 | -17.7% | 1,685,000 | 0.0% | 0.01% | -16.7% |
| Q1 2019 | $26,556,000 | +7.7% | 1,685,000 | +37.6% | 0.01% | -14.3% |
| Q4 2018 | $24,659,000 | -19.0% | 1,225,000 | 0.0% | 0.01% | 0.0% |
| Q3 2018 | $30,441,000 | -22.7% | 1,225,000 | -14.6% | 0.01% | -12.5% |
| Q2 2018 | $39,391,000 | – | 1,435,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NQ HCIF GP, Ltd. | 3,096,650 | $52,457,000 | 100.00% |
| Essex Woodlands Management, Inc. | 4,592,047 | $77,789,000 | 24.28% |
| Rhenman & Partners Asset Management AB | 126,574 | $2,144,000 | 0.62% |
| Polar Capital LLP | 1,107,272 | $18,756,000 | 0.37% |
| ArrowMark Colorado Holdings LLC | 787,923 | $13,347,000 | 0.34% |
| Lombard Odier Asset Management (USA) Corp | 250,605 | $4,245,000 | 0.29% |
| Visium Asset Management, LP | 1,000,000 | $16,940,000 | 0.24% |
| C Partners Holding GmbH | 24,000 | $407,000 | 0.13% |
| NOTTINGHAM ADVISORS, INC. | 23,018 | $390,000 | 0.10% |
| WALL STREET ASSOCIATES | 57,330 | $971,000 | 0.09% |